董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Robert C. Sledd | -- | Chairman of the Board of Director | -- | 未披露 | 未持股 | 2020-03-04 |
| Mark Beck | -- | Director | -- | 未披露 | 未持股 | 2020-03-04 |
| Mark F. McGettrick | -- | Director | -- | 未披露 | 未持股 | 2020-03-04 |
| Eddie N. Moore, Jr. | -- | Director | -- | 未披露 | 未持股 | 2020-03-04 |
| Michael Riordan | -- | Director | -- | 未披露 | 未持股 | 2020-03-04 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Andrew G. Long | 男 | Executive Vice President & Chief Financial Officer | 54 | 未披露 | 未持股 | 2020-03-04 |
| Christopher Lowery | 男 | President, Global Products | 56 | 未披露 | 未持股 | 2020-03-04 |
| Jeffery T. Jochims | 男 | Executive Vice President & Chief Operating Officer | 52 | 未披露 | 未持股 | 2020-03-04 |
| Shana C. Neal | 女 | Executive Vice President & Chief Human Resources Officer | 54 | 未披露 | 未持股 | 2020-03-04 |
| Mark P. Zacur | 男 | Executive Vice President, Chief Commercial Officer | 57 | 未披露 | 未持股 | 2020-03-04 |
| Jonathan A. Leon | 男 | Senior Vice President, Corporate Treasurer | 53 | 未披露 | 未持股 | 2020-03-04 |
| Edward A. Pesicka | 男 | President & Chief Executive Officer | 52 | 未披露 | 未持股 | 2020-03-04 |
| Nicholas J. Pace | 男 | Executive Vice President, General Counsel & Corporate Secretary | 49 | 未披露 | 未持股 | 2020-03-04 |
| Michael W. Lowry | 男 | Senior Vice President, Corporate Controller & Chief Accounting Officer | 58 | 未披露 | 未持股 | 2020-03-04 |
董事简历
中英对照 | 中文 | 英文- Robert C. Sledd
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Mark Beck
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Mark F. McGettrick
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Eddie N. Moore, Jr.
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Michael Riordan
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
高管简历
中英对照 | 中文 | 英文- Andrew G. Long
AndrewG.Long，自2019年11月11日加入公司以来，担任Owens&Minor的执行Vice President和首席财务官。在此之前，龙先生于2019年4月至2019年11月8日担任InsysTherapeutics，Inc.的首席执行官。在此之前，龙先生于2017年8月起担任Insys的首席财务官。在加入Insys之前，龙先生于2015年至2017年担任制药公司Patheon的全球财务高级副总裁。在Patheon工作之前，龙先生于2006年至2015年担任Thermo Fisher Scientific多个部门的财务Vice President。龙先生自2019年4月起担任Insys的董事会成员，该公司于2019年6月申请第11章破产保护，直到他于2019年11月8日辞职。
Andrew G. Long, Executive Vice President & Chief Financial Officer of Owens & Minor since joining the company on November 11 2019. Prior to that, Mr. Long served as the Chief Executive Officer of Insys Therapeutics, Inc. “Insys” from April 2019 to November 8 2019. Prior to that, Mr. Long served as the Chief Financial Officer of Insys from August 2017. Prior to joining Insys, Mr. Long served as senior vice president of Global Finance at Patheon, a pharmaceutical company, from 2015 to 2017. Prior to working at Patheon, Mr. Long served as Vice President of Finance for multiple divisions at Thermo Fisher Scientific from 2006 until 2015. Mr. Long has served as a Member of the Board of Directors of Insys, which filed for Chapter 11 bankruptcy protection in June 2019 from April 2019 until his resignation on November 8 2019.- AndrewG.Long，自2019年11月11日加入公司以来，担任Owens&Minor的执行Vice President和首席财务官。在此之前，龙先生于2019年4月至2019年11月8日担任InsysTherapeutics，Inc.的首席执行官。在此之前，龙先生于2017年8月起担任Insys的首席财务官。在加入Insys之前，龙先生于2015年至2017年担任制药公司Patheon的全球财务高级副总裁。在Patheon工作之前，龙先生于2006年至2015年担任Thermo Fisher Scientific多个部门的财务Vice President。龙先生自2019年4月起担任Insys的董事会成员，该公司于2019年6月申请第11章破产保护，直到他于2019年11月8日辞职。
- Andrew G. Long, Executive Vice President & Chief Financial Officer of Owens & Minor since joining the company on November 11 2019. Prior to that, Mr. Long served as the Chief Executive Officer of Insys Therapeutics, Inc. “Insys” from April 2019 to November 8 2019. Prior to that, Mr. Long served as the Chief Financial Officer of Insys from August 2017. Prior to joining Insys, Mr. Long served as senior vice president of Global Finance at Patheon, a pharmaceutical company, from 2015 to 2017. Prior to working at Patheon, Mr. Long served as Vice President of Finance for multiple divisions at Thermo Fisher Scientific from 2006 until 2015. Mr. Long has served as a Member of the Board of Directors of Insys, which filed for Chapter 11 bankruptcy protection in June 2019 from April 2019 until his resignation on November 8 2019.
- Christopher Lowery
Christopher Lowery，自2018年1月起担任Owens&Minor全球产品业务部总裁。在此之前，Lowery先生于2014年11月至2017年12月担任Halyard Health，Inc.高级副总裁兼首席运营官。Lowery从2010年4月到2014年10月担任Kimberly-Clark Health Care销售与市场营销Vice President。加入Kimberly-Clark Health Care公司之前，他曾担任Covidien公司（全球医疗保健产品公司）的多种高级市场营销与销售职务。
Christopher Lowery, President, Global Products business unit of Owens & Minor since January 2018. Prior to that, from November 2014 to December 2017 Mr. Lowery served as Senior Vice President and Chief Operating Officer at Halyard Health, Inc. From April 2010 to October 2014 Mr. Lowery served as Vice President of Sales and Marketing at Kimberly-Clark Health Care. Prior to joining Kimberly-Clark Health Care, he held several senior marketing and sales roles at Covidien, a global health care products company.- Christopher Lowery，自2018年1月起担任Owens&Minor全球产品业务部总裁。在此之前，Lowery先生于2014年11月至2017年12月担任Halyard Health，Inc.高级副总裁兼首席运营官。Lowery从2010年4月到2014年10月担任Kimberly-Clark Health Care销售与市场营销Vice President。加入Kimberly-Clark Health Care公司之前，他曾担任Covidien公司（全球医疗保健产品公司）的多种高级市场营销与销售职务。
- Christopher Lowery, President, Global Products business unit of Owens & Minor since January 2018. Prior to that, from November 2014 to December 2017 Mr. Lowery served as Senior Vice President and Chief Operating Officer at Halyard Health, Inc. From April 2010 to October 2014 Mr. Lowery served as Vice President of Sales and Marketing at Kimberly-Clark Health Care. Prior to joining Kimberly-Clark Health Care, he held several senior marketing and sales roles at Covidien, a global health care products company.
- Jeffery T. Jochims
JefferyT.Jochims，自2019年11月1日起担任执行Vice President兼首席运营官。Jochims先生于2019年4月加入Owens&Minor，并在担任COO之前担任战略与解决方案执行Vice President。Jochims先生最近担任医疗分销总裁的额外职务。Jochims先生担任医疗分销首席运营官兼总裁，负责我们医疗分销业务部门的绩效和运营，以及公司的专业服务，IT，营销，战略和持续改进职能。在加入Owens&Minor之前，Jochims先生于2015年至2019年担任梦百合，制药和生命科学行业公司的执行顾问和董事会成员。此外，在此期间，Jochims先生是4C Measures（一家初创技术企业）的联合创始人兼负责人。在此之前，从2000年到2014年，Jochims先生在Thermo Fisher Scientific担任越来越多的职位，包括2012年1月至2014年12月担任全球研究与安全市场部门（公开称为Fisher Scientific）的总裁。在此之前，他曾于2010年1月至2012年1月担任安全市场部门总裁，2007年5月至2009年12月担任全球渠道发展与战略Vice President，2000年5月至2007年5月担任Vice President部门总法律顾问兼副总法律顾问。
Jeffery T. Jochims, Executive Vice President & Chief Operating Officer since November 1 2019. Mr. Jochims joined Owens & Minor in April 2019 and served as Executive Vice President, Strategy & Solutions prior to becoming COO. Mr. Jochims recently assumed the additional duties of President, Medical Distribution. In his capacities as COO and President, Medical Distribution, Mr. Jochims is responsible for the performance and operations of our Medical Distribution business unit as well as the Company’s, specialty services, IT, marketing, strategy and continuous improvement functions. Prior to joining Owens & Minor, Mr. Jochims served from 2015 to 2019 as an executive consultant and board member to companies in the healthcare, pharmaceutical and life sciences industries. Additionally during that period, Mr. Jochims was a co-founder and principal of 4C Measures, a start-up technology business. Prior to that, from 2000 until 2014 Mr. Jochims served in positions of increasing authority at Thermo Fisher Scientific, including January 2012 - December 2014 as President of the Global Research & Safety Market division publicly known as Fisher Scientific. Prior to that, he was President of the Safety Market Division from January 2010 to January 2012 Vice President of Global Channel Development & Strategy from May 2007 to December 2009 and Vice President - Division General Counsel & Deputy General Counsel from May 2000-2007.- JefferyT.Jochims，自2019年11月1日起担任执行Vice President兼首席运营官。Jochims先生于2019年4月加入Owens&Minor，并在担任COO之前担任战略与解决方案执行Vice President。Jochims先生最近担任医疗分销总裁的额外职务。Jochims先生担任医疗分销首席运营官兼总裁，负责我们医疗分销业务部门的绩效和运营，以及公司的专业服务，IT，营销，战略和持续改进职能。在加入Owens&Minor之前，Jochims先生于2015年至2019年担任梦百合，制药和生命科学行业公司的执行顾问和董事会成员。此外，在此期间，Jochims先生是4C Measures（一家初创技术企业）的联合创始人兼负责人。在此之前，从2000年到2014年，Jochims先生在Thermo Fisher Scientific担任越来越多的职位，包括2012年1月至2014年12月担任全球研究与安全市场部门（公开称为Fisher Scientific）的总裁。在此之前，他曾于2010年1月至2012年1月担任安全市场部门总裁，2007年5月至2009年12月担任全球渠道发展与战略Vice President，2000年5月至2007年5月担任Vice President部门总法律顾问兼副总法律顾问。
- Jeffery T. Jochims, Executive Vice President & Chief Operating Officer since November 1 2019. Mr. Jochims joined Owens & Minor in April 2019 and served as Executive Vice President, Strategy & Solutions prior to becoming COO. Mr. Jochims recently assumed the additional duties of President, Medical Distribution. In his capacities as COO and President, Medical Distribution, Mr. Jochims is responsible for the performance and operations of our Medical Distribution business unit as well as the Company’s, specialty services, IT, marketing, strategy and continuous improvement functions. Prior to joining Owens & Minor, Mr. Jochims served from 2015 to 2019 as an executive consultant and board member to companies in the healthcare, pharmaceutical and life sciences industries. Additionally during that period, Mr. Jochims was a co-founder and principal of 4C Measures, a start-up technology business. Prior to that, from 2000 until 2014 Mr. Jochims served in positions of increasing authority at Thermo Fisher Scientific, including January 2012 - December 2014 as President of the Global Research & Safety Market division publicly known as Fisher Scientific. Prior to that, he was President of the Safety Market Division from January 2010 to January 2012 Vice President of Global Channel Development & Strategy from May 2007 to December 2009 and Vice President - Division General Counsel & Deputy General Counsel from May 2000-2007.
- Shana C. Neal
ShanaC.Neal，自2020年2月起担任执行Vice President兼首席人力资源官。在此之前，Neal女士于2018年3月加入Owens&Minor后担任高级副总裁兼首席人力资源官。尼尔女士是一名全球人力资源专业人士，曾于2005年至2018年在Becton Dickinson BD工作，最近担任生命科学人力资源高级副总裁，。此外，Neal女士领导BD&8217；s收购Bard和CareFusion的组织和人才整合。
Shana C. Neal, Executive Vice President & Chief Human Resources Officer since February 2020. Prior to that, Ms. Neal served as Senior Vice President & Chief Human Resources Officer, after joining Owens & Minor in March 2018. A global Human Resources professional, Ms. Neal worked for Becton Dickinson BD, from 2005 to 2018 where she most recently served as Senior Vice President, Human Resources, Life Sciences. Additionally, Ms. Neal led the organization and talent integration for BD’s acquisitions of Bard and CareFusion.- ShanaC.Neal，自2020年2月起担任执行Vice President兼首席人力资源官。在此之前，Neal女士于2018年3月加入Owens&Minor后担任高级副总裁兼首席人力资源官。尼尔女士是一名全球人力资源专业人士，曾于2005年至2018年在Becton Dickinson BD工作，最近担任生命科学人力资源高级副总裁，。此外，Neal女士领导BD&8217；s收购Bard和CareFusion的组织和人才整合。
- Shana C. Neal, Executive Vice President & Chief Human Resources Officer since February 2020. Prior to that, Ms. Neal served as Senior Vice President & Chief Human Resources Officer, after joining Owens & Minor in March 2018. A global Human Resources professional, Ms. Neal worked for Becton Dickinson BD, from 2005 to 2018 where she most recently served as Senior Vice President, Human Resources, Life Sciences. Additionally, Ms. Neal led the organization and talent integration for BD’s acquisitions of Bard and CareFusion.
- Mark P. Zacur
MarkP.Zacur，自2019年11月1日起担任执行Vice President兼首席商务官。Zacur先生于2019年6月加入Owens&Minor，并担任高级副总裁兼首席采购官至2019年11月。在加入公司之前，Zacur先生于2014年11月至2019年5月担任赛默飞世尔科学（Thermo Fisher Scientific）的国家诊断实验室分销商和运营部门Fisher梦百合的Vice President兼总经理。此前，他曾担任Thermo Fisher Scientific公司、Bayer Corporation、Reichhold Chemicals公司的多种营销、产品管理、采购和运营领导职务。Mark现任St.Clair Hospital（一家拥有330张床位的独立非营利医院，位于宾夕法尼亚州黎巴嫩山）董事。
Mark P. Zacur, Executive Vice President & Chief Commercial Officer since November 1 2019. Mr. Zacur joined Owens & Minor in June 2019 and served as Senior Vice President & Chief Procurement Officer until November 2019. Prior to joining the company, Mr. Zacur served as Vice President & General Manager of Fisher Healthcare, a national diagnostics laboratory distributor and operating division of Thermo Fisher Scientific, from November 2014 to May 2019. Previously, he held a variety of marketing, product management, procurement and operations leadership roles at Thermo Fisher Scientific, Bayer Corporation and Reichhold Chemicals. Mark currently serves on the Board of Directors at St. Clair Hospital, a 330-bed independent, non-profit hospital located in Mt. Lebanon, PA.- MarkP.Zacur，自2019年11月1日起担任执行Vice President兼首席商务官。Zacur先生于2019年6月加入Owens&Minor，并担任高级副总裁兼首席采购官至2019年11月。在加入公司之前，Zacur先生于2014年11月至2019年5月担任赛默飞世尔科学（Thermo Fisher Scientific）的国家诊断实验室分销商和运营部门Fisher梦百合的Vice President兼总经理。此前，他曾担任Thermo Fisher Scientific公司、Bayer Corporation、Reichhold Chemicals公司的多种营销、产品管理、采购和运营领导职务。Mark现任St.Clair Hospital（一家拥有330张床位的独立非营利医院，位于宾夕法尼亚州黎巴嫩山）董事。
- Mark P. Zacur, Executive Vice President & Chief Commercial Officer since November 1 2019. Mr. Zacur joined Owens & Minor in June 2019 and served as Senior Vice President & Chief Procurement Officer until November 2019. Prior to joining the company, Mr. Zacur served as Vice President & General Manager of Fisher Healthcare, a national diagnostics laboratory distributor and operating division of Thermo Fisher Scientific, from November 2014 to May 2019. Previously, he held a variety of marketing, product management, procurement and operations leadership roles at Thermo Fisher Scientific, Bayer Corporation and Reichhold Chemicals. Mark currently serves on the Board of Directors at St. Clair Hospital, a 330-bed independent, non-profit hospital located in Mt. Lebanon, PA.
- Jonathan A. Leon
JonathanA.Leon，自2018年5月起担任Owens&Minor的高级副总裁，公司财务主管。在此之前，Leon先生于2017年1月加入Owens&Minor后担任Vice President兼财务主管。加入Owens&Minor公司之前，他曾任职The Brinks Company19年，在那里他曾担任财务主管（始于1998年）。
Jonathan A. Leon, Senior Vice President, Corporate Treasurer of Owens & Minor since May 2018. Prior to that, Mr. Leon served as Vice President, Treasurer, after joining Owens & Minor in January 2017. Before joining Owens & Minor, Mr. Leon worked for the Brinks Company for nineteen years, beginning in 1998 where he served as Treasurer.- JonathanA.Leon，自2018年5月起担任Owens&Minor的高级副总裁，公司财务主管。在此之前，Leon先生于2017年1月加入Owens&Minor后担任Vice President兼财务主管。加入Owens&Minor公司之前，他曾任职The Brinks Company19年，在那里他曾担任财务主管（始于1998年）。
- Jonathan A. Leon, Senior Vice President, Corporate Treasurer of Owens & Minor since May 2018. Prior to that, Mr. Leon served as Vice President, Treasurer, after joining Owens & Minor in January 2017. Before joining Owens & Minor, Mr. Leon worked for the Brinks Company for nineteen years, beginning in 1998 where he served as Treasurer.
- Edward A. Pesicka
Edward A. Pesicka， 2008年7月被任命为赛默飞世尔科技公司高级副总裁；2014年1月被任命为首席商务官；从2008年7月到2014年1月担任顾客频道总裁；2006年11月到2008年7月担任市场研究总裁。
Edward A. Pesicka is the President and Chief Executive Officer of Owens & Minor, Inc. since March 2019. Previously Mr. Pesicka served as an independent consultant and advisor in the healthcare, life sciences and distribution industries since January 1 2016. From January 2000 through April 2015 Mr. Pesicka served in various roles of increasing responsibility at Thermo Fisher Scientific Inc., including, most recently, Chief Commercial Officer and Senior Vice President from January 2014 to April 2015. Prior to that, he was President, Customer Channels at Thermo Fisher from July 2008 to January 2014 and President, Research Market from November 2006 to July 2008. Earlier in his career, Mr. Pesicka held various Vice President-level roles in Thermo Fischer Scientific's finance department, serving as Chief Financial Officer of numerous divisions. Prior to Thermo Fisher Scientific, Mr. Pesicka spent eight years with TRW, Inc. in its finance department and three years with PricewaterhouseCoopers as an auditor.- Edward A. Pesicka， 2008年7月被任命为赛默飞世尔科技公司高级副总裁；2014年1月被任命为首席商务官；从2008年7月到2014年1月担任顾客频道总裁；2006年11月到2008年7月担任市场研究总裁。
- Edward A. Pesicka is the President and Chief Executive Officer of Owens & Minor, Inc. since March 2019. Previously Mr. Pesicka served as an independent consultant and advisor in the healthcare, life sciences and distribution industries since January 1 2016. From January 2000 through April 2015 Mr. Pesicka served in various roles of increasing responsibility at Thermo Fisher Scientific Inc., including, most recently, Chief Commercial Officer and Senior Vice President from January 2014 to April 2015. Prior to that, he was President, Customer Channels at Thermo Fisher from July 2008 to January 2014 and President, Research Market from November 2006 to July 2008. Earlier in his career, Mr. Pesicka held various Vice President-level roles in Thermo Fischer Scientific's finance department, serving as Chief Financial Officer of numerous divisions. Prior to Thermo Fisher Scientific, Mr. Pesicka spent eight years with TRW, Inc. in its finance department and three years with PricewaterhouseCoopers as an auditor.
- Nicholas J. Pace
Nicholas J. Pace，2006年加入本公司，担任高级副总裁、代理法律总顾问；2010年8月起，担任执行副总裁、法律总顾问、秘书。他有资格在弗吉尼亚州、加利福尼亚州从事法律执业。加入本公司之前，2003-2006，他是上市的二手汽车零售商CarMax, Inc.的副法律总顾问；此前，他是一名公司及证券法律师，曾任职于Morrison & Foerster, LLP。
Nicholas J. Pace, Executive Vice President, General Counsel & Corporate Secretary since May 2018. Mr. Pace joined Owens & Minor in 2016 serving as its Senior Vice President, General Counsel & Corporate Secretary. Prior to joining the company, Mr. Pace served as Executive Vice President, General Counsel & Secretary of Landmark Health, LLC, from July-December 2015. From January 2014 to July 2015 he served in simultaneous roles of Senior Vice President, Strategy & General Counsel of Landmark Health, LLC and Executive Vice President, Corporate Development & General Counsel of Avalon Health Services, LLC, two Francisco Partners portfolio companies. From March to October 2013 Mr. Pace served as Executive Vice President, Operations & Compliance for Health Diagnostic Laboratory, Inc., which filed for Chapter 11 bankruptcy protection in June 2015. Prior to that role, he served as Executive Vice President, General Counsel & Secretary of Amerigroup Corporation, where he worked from 2006-2013 until its sale to Anthem, Inc.- Nicholas J. Pace，2006年加入本公司，担任高级副总裁、代理法律总顾问；2010年8月起，担任执行副总裁、法律总顾问、秘书。他有资格在弗吉尼亚州、加利福尼亚州从事法律执业。加入本公司之前，2003-2006，他是上市的二手汽车零售商CarMax, Inc.的副法律总顾问；此前，他是一名公司及证券法律师，曾任职于Morrison & Foerster, LLP。
- Nicholas J. Pace, Executive Vice President, General Counsel & Corporate Secretary since May 2018. Mr. Pace joined Owens & Minor in 2016 serving as its Senior Vice President, General Counsel & Corporate Secretary. Prior to joining the company, Mr. Pace served as Executive Vice President, General Counsel & Secretary of Landmark Health, LLC, from July-December 2015. From January 2014 to July 2015 he served in simultaneous roles of Senior Vice President, Strategy & General Counsel of Landmark Health, LLC and Executive Vice President, Corporate Development & General Counsel of Avalon Health Services, LLC, two Francisco Partners portfolio companies. From March to October 2013 Mr. Pace served as Executive Vice President, Operations & Compliance for Health Diagnostic Laboratory, Inc., which filed for Chapter 11 bankruptcy protection in June 2015. Prior to that role, he served as Executive Vice President, General Counsel & Secretary of Amerigroup Corporation, where he worked from 2006-2013 until its sale to Anthem, Inc.
- Michael W. Lowry
Michael W. Lowry，他曾担任临时首席财务官、临时首席财务官（2013年2月以来），以及运营副总裁兼会计（2009年以来）。1988年加入Owens & Minor公司以来，他曾一直担任多种财务职务，拥有信贷管理、财政部操作和兼并和收购，以及会计经验。他于1988年加入公司，此前曾从事公共会计。
Michael W. Lowry, Senior Vice President, Corporate Controller & Chief Accounting Officer since June 2018. Prior to that, from May 2016 to June 2018 Mr. Lowry was Senior Vice President, Corporate Controller and Vice President, Corporate Controller beginning in 2013. Prior to that, from 2009 to 2013 Mr. Lowry was the Vice President, Treasurer. Mr. Lowry joined Owens & Minor in 1988.- Michael W. Lowry，他曾担任临时首席财务官、临时首席财务官（2013年2月以来），以及运营副总裁兼会计（2009年以来）。1988年加入Owens & Minor公司以来，他曾一直担任多种财务职务，拥有信贷管理、财政部操作和兼并和收购，以及会计经验。他于1988年加入公司，此前曾从事公共会计。
- Michael W. Lowry, Senior Vice President, Corporate Controller & Chief Accounting Officer since June 2018. Prior to that, from May 2016 to June 2018 Mr. Lowry was Senior Vice President, Corporate Controller and Vice President, Corporate Controller beginning in 2013. Prior to that, from 2009 to 2013 Mr. Lowry was the Vice President, Treasurer. Mr. Lowry joined Owens & Minor in 1988.